Peter J Hylands Selected Research

iridobelamal A

7/2008

Cytotoxic effects of compounds from Iris tectorum on human cancer cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter J Hylands Research Topics

Disease

2	Inflammation (Inflammations) 11/2020 - 10/2009
2	Urinary Tract Infections (Urinary Tract Infection) 01/2018 - 01/2017
2	Infections 01/2018 - 01/2017
2	Neoplasms (Cancer) 07/2008 - 08/2007
1	Fibrosis (Cirrhosis) 06/2022
1	Escherichia coli Infections 01/2018
1	Lung Neoplasms (Lung Cancer) 11/2010

Drug/Important Bio-Agent (IBA)

2	FlavonoidsIBA 06/2022 - 07/2008
2	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2018 - 01/2017
1	Phosphates (Orthophosphate)IBA 06/2022
1	3- ((5- (6- methylpyridin- 2- yl)- 4- (quinoxalin- 6- yl)- 1H- imidazol- 2- yl)methyl)benzamideIBA 06/2022
1	ChemokinesIBA 11/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2017
1	AcidsIBA 01/2017
1	Growth InhibitorsIBA 11/2010
1	Biomarkers (Surrogate Marker)IBA 11/2010
1	Complex MixturesIBA 11/2010
1	CollagenIBA 10/2009
1	TriterpenesIBA 07/2008
1	iridalIBA 07/2008
1	iridobelamal AIBA 07/2008
1	tectorigeninIBA 07/2008
1	Antineoplastic Agents (Antineoplastics)IBA 08/2007
1	AntioxidantsIBA 08/2007

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 11/2010
1	Therapeutics 11/2010